A MULTI-CENTER RETROSPECTIVE CHART REVIEW OF SURVIVAL OF PATIENTS WITH UTERINE PAPILLARY SEROUS CARCINOMA WITH AND WITHOUT A FAMILY HISTORY OF MULTIPLE ORGAN HEREDITARY CANCERS

Study ID
STU 072017-012

Cancer Related
Yes

Healthy Volunteers
No

Study Sites

  • Clements University Hospital
  • Parkland Health & Hospital System
  • UT Southwestern Ambulatory Services
  • Zale Lipshy University Hospital

Contact
Tiffany Thomas
214/648-7094
TIFFANY.THOMAS@UTSouthwestern.edu

Principal Investigator
Lavanya Palavalli Parsons, M.D.

Summary

4.1 Study Design
This will be a multi-center retrospective chart review of all patients with uPSC.

5.4 Data Management
The clinicopathologic information of patients with uterine papillary serous carcinoma will be reviewed. Demographic data such as age at diagnosis, race, and number of previous pregnancies will be collected in addition to the type of surgery and duration of chemotherapy, number of follow-up appointments, genetic testing, and other clinical information necessary to achieve the study goals. This data will be collected from computerized databases in the Division of Gynecologic oncology, as well as computerized medical records, progress notes, discharge summaries, operative notes, pathology reports, genetic reports, and other records. in order to accomplish accurate data collection, patient names and medical record numbers will be entered into the Microsoft access database until data collection is completed-at which time all identifiers will be destroyed. The Division of Gynecologic oncology, study participant specified on this protocol, will be the only investigators to have access to specific patient identifying information until the study is complete. all records will be stored only in encrypted computer hard drives or uSB drives protected by passwords or secure hard drives. university policy will be followed regarding storage of patient data on portable devices such as laptops and uSB drives. The information obtained from this study may be used to evaluate current management and survival of patients with uterine papillary serous carcinoma and also may be reported to peers at a medical conference. no patient information will be identified as a result of this review.

Participant Eligibility

-Pathologic diagnosis of uterine papillary serous carcinoma of the uterus from 1/1/1976 to July 1 2017
-Age >= 18 years.